These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6098581)

  • 1. Isolation and characterization of monoclonal antibodies to Bordetella pertussis.
    Frank DW; Parker CD
    J Biol Stand; 1984 Oct; 12(4):353-65. PubMed ID: 6098581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a 69-kilodalton nonfimbrial protein as an agglutinogen of Bordetella pertussis.
    Brennan MJ; Li ZM; Cowell JL; Bisher ME; Steven AC; Novotny P; Manclark CR
    Infect Immun; 1988 Dec; 56(12):3189-95. PubMed ID: 2903126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and comparative bactericidal activity of monoclonal antibodies to Bordetella pertussis lipo-oligosaccharide A.
    Archambault D; Rondeau P; Martin D; Brodeur BR
    J Gen Microbiol; 1991 Apr; 137(4):905-11. PubMed ID: 1713258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and characterization of monoclonal antibodies directed against Bordetella pertussis lipopolysaccharide.
    Gustafsson B; Lindquist U; Andersson M
    J Clin Microbiol; 1988 Feb; 26(2):188-93. PubMed ID: 2893806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of Bordetella pertussis antigens using monoclonal antibodies.
    Larsen FS; Selmer JC; Hertz JB
    Acta Pathol Microbiol Immunol Scand C; 1984 Oct; 92(5):271-7. PubMed ID: 6097091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of pertussigen (pertussis toxin) on the mouse protective activity of vaccines made from Bordetella species.
    Munoz JJ; Peacock MG
    Microbiol Immunol; 1989; 33(4):341-55. PubMed ID: 2549344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies.
    Li ZM; Brennan MJ; David JL; Carter PH; Cowell JL; Manclark CR
    Infect Immun; 1988 Dec; 56(12):3184-8. PubMed ID: 2903125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Obtaining monoclonal antibodies to Bordetella pertussis antigens].
    Sviridov VV; Kozhevnikova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Sep; (9):67-70. PubMed ID: 2866646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface antigens of Bordetella pertussis.
    Parker CD; Armstrong SK; Frank DW
    Adv Exp Med Biol; 1985; 185():117-27. PubMed ID: 2866677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic analysis of the saccharide moiety of the lipooligosaccharide of Bordetella pertussis.
    Brodeur BR; Martin D; Hamel J; Shahin RD; Laferrière C
    Springer Semin Immunopathol; 1993; 15(2-3):205-15. PubMed ID: 8256198
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoelectron microscopy of antigens of Bordetella pertussis using monoclonal antibodies to agglutinogens 2 and 3, filamentous haemagglutinin, pertussis toxin, pertactin and adenylate cyclase toxin.
    Blom J; Heron I; Hendley JO
    APMIS; 1994 Sep; 102(9):681-9. PubMed ID: 7946271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
    Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agglutinating monoclonal antibodies that specifically recognize lipooligosaccharide A of Bordetella pertussis.
    Li ZM; Cowell JL; Brennan MJ; Burns DL; Manclark CR
    Infect Immun; 1988 Mar; 56(3):699-702. PubMed ID: 2893776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
    Watanabe M; Nagai M
    Infect Immun; 2001 Nov; 69(11):6981-6. PubMed ID: 11598073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fimbrial typing of Bordetella pertussis isolates: agglutination with polyclonal and monoclonal antibodies.
    Xing DK; Ramakrishnan S; Newland P; Corbel MJ
    J Clin Microbiol; 2001 Nov; 39(11):4220. PubMed ID: 11712516
    [No Abstract]   [Full Text] [Related]  

  • 16. [The isolation of monoclonal antibodies to strains of Mycobacterium leprae passed through laboratory animals].
    Ibragimov ChD; Iushchenko AA; Diachina MN; Sviridov VV; Chernousova LN
    Probl Tuberk; 1993; (6):45-7. PubMed ID: 8290533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies against Pseudomonas aeruginosa outer membrane antigens: isolation and characterization.
    Hancock RE; Wieczorek AA; Mutharia LM; Poole K
    Infect Immun; 1982 Jul; 37(1):166-71. PubMed ID: 6809625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactions between Bordetella pertussis and twenty-eight other bacterial species.
    Høiby N; Hertz JB; Andersen V
    Acta Pathol Microbiol Scand B; 1976 Dec; 84B(6):395-400. PubMed ID: 187010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies against surface antigens of Bacteroides gingivalis.
    Naito Y; Okuda K; Kato T; Takazoe I
    Infect Immun; 1985 Oct; 50(1):231-5. PubMed ID: 4044037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A recombinant iron transport protein from Bordetella pertussis confers protection against Bordetella parapertussis.
    Alvarez Hayes J; Oviedo JM; Valdez H; Laborde JM; Maschi F; Ayala M; Shah R; Fernandez Lahore M; Rodriguez ME
    Microbiol Immunol; 2017 Oct; 61(10):407-415. PubMed ID: 28857261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.